A recent study conducted by researchers at Monash University in Melbourne has found that daily intake of 100mg of aspirin can significantly reduce the risk of diabetes in seniors. While many seniors take aspirin regularly to prevent heart attacks or strokes, studies have shown that this can increase the risk of heart failure and anemia. The study, presented at the annual meeting of the European Association for the Study of Diabetes, was based on health data from the ASPREE study of seniors aged 65 and over who had no cardiovascular disease, dementia, or physical disabilities at the start of the study. The 16,209 participants were divided into two groups, with one group receiving daily 100mg aspirin and the other receiving a placebo. The occurrence of diabetes was determined by various factors, including self-reports, the start of blood sugar-lowering medication, or increased fasting blood sugar levels. During the median observation period of 4.7 years, 995 new cases of diabetes were registered. Compared to the placebo group, these occurred 15% less frequently in the aspirin group.

The study’s lead researcher, Professor Sophia Zoungas, emphasized the need for further investigation into the role of anti-inflammatory drugs such as aspirin in diabetes prevention. However, she also noted that previous studies, including the ASPREE study from 2018, did not show an extension of healthy, independent life through aspirin. Instead, a significantly increased risk of bleeding was found, particularly in the gastrointestinal tract. Current medical guidelines recommend that older adults should only take aspirin for a specific medical reason, such as after a heart attack. Despite the potential interest generated by the new study results, there are currently no changes in clinical recommendations regarding the use of aspirin in older adults.

In conclusion, while the daily intake of 100mg aspirin can reduce the risk of diabetes in seniors, it is not recommended for preventive use without a specific medical reason. The study highlights the need for further investigation into the role of anti-inflammatory drugs in diabetes prevention, but it also underscores the potential risks associated with aspirin use in older adults. As always, it is important to consult with a healthcare professional before starting any new medication or treatment.

Leave a Reply

Your email address will not be published. Required fields are marked *